Galectin Therapeutics
GALT
GALT
62 hedge funds and large institutions have $13.6M invested in Galectin Therapeutics in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
56% less call options, than puts
Call options by funds: $76K | Put options by funds: $171K
Holders
62
Holding in Top 10
–
Calls
$76K
Puts
$171K
Top Buyers
| 1 | +$1.51M | |
| 2 | +$542K | |
| 3 | +$223K | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$67K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$57.5K |
Top Sellers
| 1 | -$393K | |
| 2 | -$270K | |
| 3 | -$195K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$138K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$135K |